Semler Scientific, Inc. (SMLR)
NASDAQ: SMLR · Real-Time Price · USD
28.36
-2.39 (-7.77%)
At close: Oct 7, 2025, 4:00 PM EDT
28.73
+0.37 (1.30%)
After-hours: Oct 7, 2025, 7:58 PM EDT
Semler Scientific Revenue
Semler Scientific had revenue of $8.22M in the quarter ending June 30, 2025, a decrease of -43.19%. This brings the company's revenue in the last twelve months to $42.98M, down -30.39% year-over-year. In the year 2024, Semler Scientific had annual revenue of $56.29M, down -17.44%.
Revenue (ttm)
$42.98M
Revenue Growth
-30.39%
P/S Ratio
6.01
Revenue / Employee
$544,025
Employees
79
Market Cap
429.43M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.29M | -11.89M | -17.44% |
Dec 31, 2023 | 68.18M | 11.50M | 20.28% |
Dec 31, 2022 | 56.69M | 3.66M | 6.90% |
Dec 31, 2021 | 53.03M | 14.42M | 37.36% |
Dec 31, 2020 | 38.60M | 5.84M | 17.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SMLR News
- 2 days ago - SMLR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific - GlobeNewsWire
- 7 days ago - Shareholders who lost money in shares of Semler Scientific (NASDAQ: SMLR) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 14 days ago - SEMLER SCIENTIFIC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR - Business Wire
- 16 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific - GlobeNewsWire
- 24 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific - PRNewsWire
- 5 weeks ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc. (SMLR) - GlobeNewsWire
- 2 months ago - Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025 - PRNewsWire